News & Events
Introduction SensEye G CoViD-19 SARS-CoV-2 Variants MP5
After SensEye launched the first CoViD-19 SPR-sensor in May last year, SensEye now launches the first sensor to study the simultaneous antibody binding to the trimeric spike protein of SARS-CoV-2 variants of concern. Beside the spike protein of the wild type variant of the virus (Wuhan), the sensor includes the UK (B.1.1.7), South Africa (B.1.351) and Brazil (P.1) variants. For ease of data interpretation, wild type S1 (RBD containing) protein has also been included on this SensEye.
Highly sensitive COVID-19 sensor for high throughput antibody screening.
Screen the immune response of a large number of COVID-19 samples in a short time.
PEGS Europe 2019
PEGS Europe 2018
IBIS User Meeting NL 2018
On October 19th 2018, IBIS Technologies organized it’s first NL-User Meeting.